Katherine Wasson

Loyola University Chicago, Chicago, IL, USA

Are you Katherine Wasson?

Claim your profile

Publications (8)24.38 Total impact

  • Article: Behavior equipoise: is it ready for prime time?
    Katherine Wasson
    The American journal of bioethics: AJOB 02/2011; 11(2):14-6. · 4.00 Impact Factor
  • Article: Medical and genetic enhancements: ethical issues that will not go away.
    Katherine Wasson
    The American journal of bioethics: AJOB 01/2011; 11(1):21-2. · 4.00 Impact Factor
  • Article: Direct-to-consumer genomics and research ethics: should a more robust informed consent process be included?
    Katherine Wasson
    The American journal of bioethics: AJOB 01/2009; 9(6-7):56-8. · 4.00 Impact Factor
  • Article: Consumer alert: ethical issues raised by the sale of genetic tests directly to consumers.
    Katherine Wasson
    The American journal of bioethics: AJOB 07/2008; 8(6):16-8. · 4.00 Impact Factor
  • Article: Fatal disseminated encephalitozoonosis in a captive, adult Goeldi's monkey (Callimico goeldii) and subsequent serosurvey of the exposed conspecifics.
    [show abstract] [hide abstract]
    ABSTRACT: A captive, adult male Goeldi's monkey (Callimico goeldii) (GM) presented in acute respiratory distress 4 yr after importation into the United States from Europe. Radiographs and echocardiogram were consistent with heart failure. The monkey died within 24 hr of presentation. Necropsy findings included multicentric arteritis and aortitis with aneurysm associated with microsporidian organisms morphologically consistent with Encephalitozoon species. Polymerase chain reaction confirmed organisms were Encephalitozoon cuniculi. Sequence analysis of amplicons generated by using primers specific for the polar tube protein of E. cuniculi determined the organism to be genotype II. An E. cuniculi serosurvey of potentially exposed conspecifics that represented approximately 40% of the captive GM population in the United States was conducted. Multiple individuals that had been imported from Europe with the individual of this report were seropositive via an immunofluorescent antibody assay for E. cuniculi. Multiple samples were available from 3 individuals that demonstrated a decrease in titer or reversion to seronegative status within 3 yr of initial positive status. All other GM were negative on serology. This case is unique in that the genotype identified (genotype II) was different than the genotype (genotype III) reported in other New World primate (NWP) species, the patterns of arteritis were different from the typical pattern of microsporidial vasculitis described in other species, and clinical disease was observed in an adult. Most reported cases of clinical disease secondary to E. cuniculi in NWP have been in neonates and juveniles.
    Journal of Zoo and Wildlife Medicine 06/2008; 39(2):221-7. · 0.38 Impact Factor
  • Article: Direct-to-consumer online genetic testing and the four principles: an analysis of the ethical issues.
    Katherine Wasson, E David Cook, Kathy Helzlsouer
    [show abstract] [hide abstract]
    ABSTRACT: The development of genetic tests marketed and sold direct-to-consumers (DTC) via the internet raises moral concerns and debate about their appropriateness and ethical and clinical significance. These tests are offered for a wide range of diseases and conditions, and the mutations have variable penetrance and associated risk. A number of these tests lack data on their accuracy and reliability, making interpretation of results difficult. DTC genetic testing is undertaken outside the context of the physician-patient relationship and may lack appropriate individual and family genetic counseling, leaving the consumer vulnerable to potential harms, such as misinterpretation of results, including false positive or false reassurance, with limited or no benefits. Beauchamp and Childress's four principles of biomedical ethics provide a framework for analyzing the ethical issues raised by DTC genetic testing. We argue that the potential harms outweigh the potential benefits of such tests, that respect for autonomy should be limited in light of potential harm from DTC testing, and that the availability of genetic testing over the internet may be considered unfair and unjust and affect resource allocation by placing an unfair burden on primary care physicians. In light of the moral issues posed by these tests, practical responses are suggested in the areas of consumer education, medical education, and interaction with commercial companies.
    Ethics & medicine: a Christian perspective on issues in bioethics 02/2006; 22(2):83-91.
  • Article: Pellegrino and medicine: a critical revision.
    Katherine Wasson, E David Cook
    The American journal of bioethics: AJOB 6(2):90-1. · 4.00 Impact Factor
  • Article: Altruism and pediatric oncology trials: it does not tip the decision-making scales.
    Katherine Wasson
    The American journal of bioethics: AJOB 6(5):48. · 4.00 Impact Factor

Institutions

  • 2009–2011
    • Loyola University Chicago
      • Neiswanger Institute for Bioethics and Health Policy
      Chicago, IL, USA
  • 2008
    • Loyola University
      New Orleans, LA, USA
  • 2006
    • National Institutes of Health
      • Division of Cancer Prevention
      Bethesda, MD, USA